Balancing Surgical Innovation with Indications: A Multicenter Retrospective Comparison of Reduced-Port Distal Gastrectomy Using da Vinci SP Versus Multi-Port Robotic Platforms from the KLASS-13 Cohort
spRRDG exhibited lower rLNs than cRRDG but remained within an oncologically acceptable range. Comparable complication rates and significantly improved ERAS outcomes suggest spRRDG is safe and feasible; however, its clinical application should remain limited to early gastric cancer until robust evidence from prospective studies emerges.
Authors
- C. W. Lee
- Jae-Moon Bae (ORCID: https://orcid.org/0000-0003-3928-0743)
- Sung Hyun Park (ORCID: https://orcid.org/0000-0001-5116-728X)
- Han Hong Lee
- Y. Jin Suh
- Jae Hun Chung
- Hyoung-il Kim
- Young Suk Park
- Yoo Min Kim
Institutions
- University Health System (US)
- Samsung Medical Center (KR)
- Seoul National University Bundang Hospital (KR)
- Ansan University (KR)
- Pusan National University Yangsan Hospital (KR)
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- Yonsei University Health System (KR)
- Korea University (JP)
- Sungkyunkwan University (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- Cancers
- Published
- 2026-03-04
- DOI
- https://doi.org/10.3390/cancers18050823
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00